These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4650657)

  • 1. Control of fertility by monthyl injections of a mixture of norgestrel and a long-acting estrogen. A preliminary report.
    de Souza JC; Coutinho EM
    Contraception; 1972 May; 5(5):395-9. PubMed ID: 4650657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of high-dose estrogens versus low-dose ethinylestradiol and norgestrel combination in postcoital interception: a study in 493 women.
    Van Santen MR; Haspels AA
    Fertil Steril; 1985 Feb; 43(2):206-13. PubMed ID: 3881294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol and d-norgestrel.
    Mishell DR; Moore DE; Roy S; Brenner PF; Page MA
    Am J Obstet Gynecol; 1978 Jan; 130(1):55-62. PubMed ID: 619648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of low-dose progestogen-estrogen combination (WL-20) on the menstrual cycle of sexually active women of childbearing age.
    Sartoretto JN; Moraes R
    Contraception; 1974 Aug; 10(2):127-34. PubMed ID: 4418507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical studies with a low dose estrogen-progestogen combination.
    Sartoretto JN; Ortega-Recio JC; Moraes R; Filho FN
    Contraception; 1977 May; 15(5):563-70. PubMed ID: 880827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal postcoital contraception with an ethinylestradiol-norgestrel combination and two danazol regimens.
    Zuliani G; Colombo UF; Molla R
    Eur J Obstet Gynecol Reprod Biol; 1990 Dec; 37(3):253-60. PubMed ID: 2227068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. III. Effect of preovulatory administration following the luteinizing hormone surge on ovarian steroidogenesis.
    Ling WY; Wrixon W; Acorn T; Wilson E; Collins J
    Fertil Steril; 1983 Nov; 40(5):631-6. PubMed ID: 6628707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial effects of levonorgestrel and estradiol: A Scanning electron microscopic study of the luminal epithelium.
    Nilsson O; Englund D; Weiner E; Victor A
    Contraception; 1980 Jul; 22(1):71-83. PubMed ID: 6774851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I comparative clinical trial with subdermal implants--bioabsorbable levonorgestrel or norethisterone pellet fused with cholesterol.
    Joshi UM; Joshi JV; Donde UM; Sankoli GM; Virkar KD; Saxena BN
    Contraception; 1985 Jan; 31(1):71-82. PubMed ID: 3921309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovulation inhibition with a log-acting injectable. II. The cycling effects of varying progestagen-estrogen combinations.
    Rizkallah TH; Taymor ML
    Am J Obstet Gynecol; 1966 Jan; 94(2):161-4. PubMed ID: 5900652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some estrogenic effects of two oral contraceptives consisting of norgestrel and two different doses of ethynylestradiol.
    Miller JF; Fotherby K; Bye PG; Elstein M
    Contraception; 1979 Jul; 20(1):5-10. PubMed ID: 573191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception.
    Glasier A; Thong KJ; Dewar M; Mackie M; Baird DT
    N Engl J Med; 1992 Oct; 327(15):1041-4. PubMed ID: 1522839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of vaginal administration of low-dose oral contraceptive tablets on human ovulation.
    Souka AR; el Sokkary H; Kamel M; Hassan M
    Contraception; 1986 Apr; 33(4):365-71. PubMed ID: 3731776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pill-a-month as an oral contraceptive.
    Hefnawi F; Hassanein M; Younis N
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):1-17. PubMed ID: 12256024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of ovarian function by Microgynon 30 in day 1 and day 5 "starters".
    Taylor DR; Anthony FW; Dennis KJ
    Contraception; 1986 May; 33(5):463-71. PubMed ID: 3757512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and endocrinologic study of continuous levonorgestrel administration from subcutaneous solid polydimethylsiloxane rods.
    Roy S; Stanczyk F; Mishell DR; Lumkin M; Gentzschein E
    Contraception; 1980 Jun; 21(6):595-615. PubMed ID: 6775868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravaginal and intracervical devices for the delivery of fertility regulating agents.
    J Steroid Biochem; 1979 Jul; 11(1B):461-7. PubMed ID: 491617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.